INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 222 filers reported holding INSMED INC in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,797,272 | +24.6% | 150,387 | +4.1% | 1.15% | +22.1% |
Q2 2023 | $3,048,190 | +24.3% | 144,464 | +0.5% | 0.94% | -6.8% |
Q1 2023 | $2,451,688 | -1.4% | 143,794 | +15.5% | 1.01% | +42.3% |
Q4 2022 | $2,486,811 | -48.5% | 124,465 | -44.4% | 0.71% | -56.4% |
Q3 2022 | $4,825,000 | +15.2% | 224,016 | +5.4% | 1.63% | +26.5% |
Q2 2022 | $4,190,000 | +74.7% | 212,482 | +108.2% | 1.29% | +29.9% |
Q1 2022 | $2,399,000 | -12.5% | 102,067 | +1.4% | 0.99% | -10.6% |
Q4 2021 | $2,741,000 | -43.0% | 100,621 | -42.4% | 1.11% | -59.1% |
Q3 2021 | $4,808,000 | -4.8% | 174,588 | -1.6% | 2.72% | +20.7% |
Q2 2021 | $5,050,000 | -22.3% | 177,433 | -7.0% | 2.25% | -36.5% |
Q1 2021 | $6,499,000 | +11.6% | 190,810 | +9.0% | 3.54% | +4.7% |
Q4 2020 | $5,826,000 | – | 175,000 | – | 3.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |